BSECompany Update1d ago · 14 Nov 2026, 08:28 pm

Intimation for appointment of Additional Director (Non-Executive Independent Director) of the Company is attached herewith.

Gufic Biosciences Ltd · 509079

✦ AI SummaryMgmt Change

Gufic Biosciences Ltd has announced the appointment of Dr. Reeta Shah as an Additional Director (Non-Executive Independent Director) of the Company, effective December 01, 2026, subject to shareholder approval.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Change in Directorate

Attachments (1)

📄

48feb415-0944-47c9-b87d-59f4835ebd7e.pdf

pdf

Download →
View document text
347/LG/SE/NOV/2026/GBSL November 14, 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code : 509079 Scrip Symbol : GUFICBIO Subject: Appointment of Additional Director (Non-Executive Independent Director) of the Company Dear Sir/Madam, Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), we wish to inform that the Board of Directors of the Company at its meeting held today, i.e. on Saturday, November 14, 2026, has approved the appointment of Dr. Reeta Shah (DIN: 07141304) as an Additional Director (Non-Executive Independent Director) of the Company, for the first term of 5 consecutive years with effect from December 01, 2026, subject to approval of the shareholders. Further, it is hereby confirmed that Dr. Reeta Shah is not debarred from holding the office of Director by virtue of any order passed by Securities and Exchange Board of India (SEBI) or any other such authority. The details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed herewith as “Annexure The meeting of the Board of Directors commenced at 5:00 p.m. and concluded at 06:35 p.m. Kindly take the same on your record. Thanking You, Yours truly, For Gufic Biosciences Limited Ami Shah Company Secretary & Compliance Officer Membership No. A39579 Encl.: As above Annexure – B Particulars Details Reason for change viz. Appointment of Dr. Reeta Shah (DIN: 07141304) as an appointment, re- Additional Director (Non-Executive Independent Director) of appointment, resignation, the Company removal, death or otherwise; Date of appointment/ re- Appointment with effect from December 01, 2026 appointment/cessation as applicable Term of appointment/ re- Appointed for the first term of 5 consecutive years with effect appointment from December 01, 2026, subject to approval of the shareholders. Brief profile (in case of Dr. Reeta Shah is a Chartered Accountant with a Ph.D. in appointment) Finance from IIT Bombay, an LL.B., and three Master's degrees. With over 38 years of experience in Finance, Education and Administration, she has held leadership positions at SIES College and ITM EEC and has been associated with premier institutions such as IIT Bombay, IIT Delhi, and IIM Indore. She served as an Independent Director at Shemaroo Entertainment Limited for 10 years. She is also a TEDx speaker, international keynote speaker, growth strategist, and an active panelist and trainer at conferences and seminars organised by ICAI and other reputed institutions. Disclosure of relationships Dr. Reeta Shah is not related to any Director of the Company. between directors (in case of appointment of director)